查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807691

肿瘤分子诊断药的全球市场:市场规模·占有率·趋势，产业分析 (各产品·各类型·各技术·各地区)，2025～2034年的市场预测

Oncology Based Molecular Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Type, By Technology, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，预计到 2034 年，肿瘤分子诊断市场规模将达到 61.2 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

肿瘤分子诊断是一种先进的工具，可以解读癌症相关的基因和分子变异，从而指导精准的临床决策。随着精准肿瘤学日益受到关注，肿瘤分子诊断市场正在不断扩张。精准肿瘤学利用分子层面的洞察，根据个别肿瘤特征客製化治疗策略。这一趋势反映了癌症治疗领域更广泛的变化：从仿製药转向标靶治疗，以提高疗效并最大限度地减少副作用。对此类个人化解决方案日益增长的需求，正在推动持续的技术创新，并将分子诊断融入标准的肿瘤学工作流程中。

液体活检等非侵入性诊断技术日益普及，无需手术即可提供即时监测和早期检测，进一步拓展了成长机会。这些技术进步使得动态评估疾病进展和治疗反应成为可能，拓展了分子诊断的临床应用。随着医疗保健提供者寻求透过微创、高精度的诊断来改善患者预后，这些技术的开发和应用预计将继续成为肿瘤诊断领域的前沿。

基于肿瘤的分子诊断市场：分析概述

按产品划分，试剂细分市场是各种分子诊断和检测技术（例如PCR、定序和杂交）必不可少的组成部分，其收入占有率高达58.61%，占市场领先地位。

按技术划分，定序技术能够提供对癌症基因组的详细、高解析度洞察，预计将成为成长最快的细分市场。

得益于先进的医疗基础设施、强大的研究生态系统以及创新诊断技术的早期应用，北美在肿瘤分子诊断市场占主导地位，2024 年占全球市场占有率的 44.69%。

预计在预测期内，亚太市场将成长最快，这得益于支持性法规、高诊断​​标准以及对个人化癌症治疗日益增长的需求。

全球肿瘤分子诊断市场的领导公司包括 Artivion, Inc.、Aroa Oncology Based Molecular Diagnostics、B. Braun SE、Baxter、BD、INTEGRA LIFESCIENCES、Johnson & Johnson Services, Inc.、Medtronic、Pfizer Inc.、Sanofi 和 Stryker。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球肿瘤分子诊断药市场洞察

  • 市场概述
  • 肿瘤分子诊断药的市场动态
    • 促进因素和机会
      • 全球癌症发生率和盛行率上升
      • 分子肿瘤检测技术的进步
    • 限制因素与课题
      • 高昂的研发与营运成本
    • 公众舆论与隐私先例
  • PESTEL 分析
  • 肿瘤分子诊断市场趋势
  • 价值链分析

第5章 全球肿瘤分子诊断药市场:各类型

  • 关键分析结果
  • 简介
  • 乳癌
  • 摄护腺癌
  • 大肠直肠癌
  • 子宫颈癌
  • 肝癌
  • 肺癌
  • 血液癌
  • 肾癌
  • 其他

第6章 全球肿瘤分子诊断药市场:各产品

  • 主要的分析结果
  • 简介
  • 设备
  • 试剂
  • 其他

第7章 全球肿瘤分子诊断药市场:各技术

  • 主要的分析结果
  • 简介
  • PCR
  • 原位 杂合反应
  • INAAT
  • 晶片·微阵列
  • 质谱分析
  • 定序
  • TMA
  • 其他

第8章 全球肿瘤分子诊断药市场:各地区

  • 主要的分析结果
  • 简介
    • 肿瘤分子诊断药市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:各类型(2020～2034年)
    • 北美:各产品(2020～2034年)
    • 北美:各技术(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型(2020～2034年)
    • 欧洲:各产品(2020～2034年)
    • 欧洲:各技术(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型(2020～2034年)
    • 亚太地区:各产品(2020～2034年)
    • 亚太地区:各技术(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型(2020～2034年)
    • 中东·非洲:各产品(2020～2034年)
    • 中东·非洲:各技术(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各类型(2020～2034年)
    • 南美:各产品(2020～2034年)
    • 南美:各技术(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Abbott
  • Bayer AG
  • BD
  • Cepheid
  • Agilent Technologies, Inc.
  • Danaher
  • Hologic, Inc.
  • Qiagen
  • F. Hoffmann-La Roche Ltd.
  • Siemens
  • Sysmex
Product Code: PM6200

The oncology-based molecular diagnostics market size is expected to reach USD 6.12 billion by 2034, according to a new study by Polaris Market Research. The report "Oncology Based Molecular Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Type, By Technology, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Oncology-based molecular diagnostics are advanced tools that decode cancer-related genetic and molecular alterations to guide precise clinical decision-making. The oncology-based molecular diagnostics market is expanding due to the growing focus on precision oncology, where molecular insights are increasingly being used to tailor treatment strategies based on individual tumor profiles. This trend reflects a broader transformation in cancer care, moving from generalized therapies to targeted approaches that improve efficacy and minimize adverse effects. The growing demand for such personalized solutions is driving continuous innovation and integration of molecular diagnostics into standard oncology workflows.

The increasing adoption of noninvasive diagnostic techniques, such as liquid biopsy, which offer real-time monitoring and early detection without the need for surgical procedures, further contributes to the growth opportunities. These advancements are expanding the clinical utility of molecular diagnostics by enabling dynamic assessment of disease progression and treatment response. The development and utilization of such technologies are expected to remain at the forefront of the oncology diagnostics landscape as healthcare providers seek to enhance patient outcomes through minimally invasive and highly accurate diagnostics.

Oncology Based Molecular Diagnostics Market Report Highlights

In terms of product, the reagents segment led the market with 58.61% revenue share, as they are essential for various molecular diagnostic tests such as PCR, sequencing, and hybridization.

Based on technology, the sequencing segment is projected to grow the fastest due to its ability to deliver detailed, high-resolution cancer genomic insights.

North America dominated the oncology molecular diagnostics market with a 44.69% global share in 2024, supported by advanced healthcare infrastructure, a robust research ecosystem, and early adoption of innovative diagnostic technologies.

Asia Pacific market is expected to grow the fastest during the forecast period, fueled by supportive regulations, high diagnostic standards, and rising demand for personalized cancer care.

A few global key players in the oncology based molecular diagnostics market include Artivion, Inc.; Aroa Oncology Based Molecular Diagnostics; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.

Polaris Market Research has segmented the oncology based molecular diagnostics market report on the basis of type, product, technology, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Breast Cancer

Prostate Cancer

Colorectal Cancer

Cervical Cancer

Liver Cancer

Lung Cancer

Blood Cancer

Kidney Cancer

Others

By Product Outlook (Revenue, USD Billion, 2020-2034)

Instruments

Reagents

Others

By Technology Outlook (Revenue, USD Billion, 2020-2034)

PCR

In situ hybridization

INAAT

Chips and microarrays

Mass spectrometry

Sequencing

TMA

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oncology Based Molecular Diagnostics Market Insights

  • 4.1. Oncology Based Molecular Diagnostics Market - Market Snapshot
  • 4.2. Oncology Based Molecular Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidence and Prevalence of Cancer Globally
      • 4.2.1.2. Rising Advancement in Molecular Oncology Tests Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High R&D and operational costs
    • 4.2.3. Public opinion and privacy legal precedents
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Oncology Based Molecular Diagnostics Market Trends
  • 4.6. Value Chain Analysis

5. Global Oncology Based Molecular Diagnostics Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Breast Cancer
    • 5.3.1. Global Oncology Based Molecular Diagnostics Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
  • 5.4. Prostate Cancer
    • 5.4.1. Global Oncology Based Molecular Diagnostics Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
  • 5.5. Colorectal Cancer
    • 5.5.1. Global Oncology Based Molecular Diagnostics Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 5.6. Cervical Cancer
    • 5.6.1. Global Oncology Based Molecular Diagnostics Market, by Cervical Cancer, by Region, 2020-2034 (USD Billion)
  • 5.7. Liver Cancer
    • 5.7.1. Global Oncology Based Molecular Diagnostics Market, by Liver Cancer, by Region, 2020-2034 (USD Billion)
  • 5.8. Lung Cancer
    • 5.8.1. Global Oncology Based Molecular Diagnostics Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 5.9. Blood Cancer
    • 5.9.1. Global Oncology Based Molecular Diagnostics Market, by Blood Cancer, by Region, 2020-2034 (USD Billion)
  • 5.10. Kidney Cancer
    • 5.10.1. Global Oncology Based Molecular Diagnostics Market, by Kidney Cancer, by Region, 2020-2034 (USD Billion)
  • 5.11. Others
    • 5.11.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Oncology Based Molecular Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Oncology Based Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 6.4. Reagents
    • 6.4.1. Global Oncology Based Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Oncology Based Molecular Diagnostics Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. PCR
    • 7.3.1. Global Oncology Based Molecular Diagnostics Market, by PCR, by Region, 2020-2034 (USD Billion)
  • 7.4. In situ hybridization
    • 7.4.1. Global Oncology Based Molecular Diagnostics Market, by In situ hybridization, by Region, 2020-2034 (USD Billion)
  • 7.5. INAAT
    • 7.5.1. Global Oncology Based Molecular Diagnostics Market, by INAAT, by Region, 2020-2034 (USD Billion)
  • 7.6. Chips and microarrays
    • 7.6.1. Global Oncology Based Molecular Diagnostics Market, by Chips and microarrays, by Region, 2020-2034 (USD Billion)
  • 7.7. Mass spectrometry
    • 7.7.1. Global Oncology Based Molecular Diagnostics Market, by Mass spectrometry, by Region, 2020-2034 (USD Billion)
  • 7.8. Sequencing
    • 7.8.1. Global Oncology Based Molecular Diagnostics Market, by Sequencing, by Region, 2020-2034 (USD Billion)
  • 7.9. TMA
    • 7.9.1. Global Oncology Based Molecular Diagnostics Market, by TMA, by Region, 2020-2034 (USD Billion)
  • 7.10. Others
    • 7.10.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Oncology Based Molecular Diagnostics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Oncology Based Molecular Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Oncology Based Molecular Diagnostics Market - North America
    • 8.3.1. North America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.3.3. North America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.4. Oncology Based Molecular Diagnostics Market - US
      • 8.3.4.1. US: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.5. Oncology Based Molecular Diagnostics Market - Canada
      • 8.3.5.1. Canada: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.4. Oncology Based Molecular Diagnostics Market - Europe
    • 8.4.1. Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.4. Oncology Based Molecular Diagnostics Market - UK
      • 8.4.4.1. UK: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.5. Oncology Based Molecular Diagnostics Market - France
      • 8.4.5.1. France: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.6. Oncology Based Molecular Diagnostics Market - Germany
      • 8.4.6.1. Germany: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.7. Oncology Based Molecular Diagnostics Market - Italy
      • 8.4.7.1. Italy: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.8. Oncology Based Molecular Diagnostics Market - Spain
      • 8.4.8.1. Spain: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.9. Oncology Based Molecular Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.10. Oncology Based Molecular Diagnostics Market - Russia
      • 8.4.10.1. Russia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.11. Oncology Based Molecular Diagnostics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.5. Oncology Based Molecular Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.4. Oncology Based Molecular Diagnostics Market - China
      • 8.5.4.1. China: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.5. Oncology Based Molecular Diagnostics Market - India
      • 8.5.5.1. India: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.6. Oncology Based Molecular Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.7. Oncology Based Molecular Diagnostics Market - Japan
      • 8.5.7.1. Japan: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.8. Oncology Based Molecular Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.9. Oncology Based Molecular Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.10. Oncology Based Molecular Diagnostics Market - Australia
      • 8.5.10.1. Australia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.11. Oncology Based Molecular Diagnostics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.6. Oncology Based Molecular Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.4. Oncology Based Molecular Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.5. Oncology Based Molecular Diagnostics Market - UAE
      • 8.6.5.1. UAE: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.6. Oncology Based Molecular Diagnostics Market - Israel
      • 8.6.6.1. Israel: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.7. Oncology Based Molecular Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.8. Oncology Based Molecular Diagnostics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.7. Oncology Based Molecular Diagnostics Market - Latin America
    • 8.7.1. Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.4. Oncology Based Molecular Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.5. Oncology Based Molecular Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.6. Oncology Based Molecular Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.7. Oncology Based Molecular Diagnostics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BD
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cepheid
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Agilent Technologies, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Danaher
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hologic, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Qiagen
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Sysmex
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 3 Global Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 North America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 6 North America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 7 US: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 8 US: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 9 US: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 10 Canada: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 12 Canada: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 13 Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 15 Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 16 UK: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 18 UK: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 19 France: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 21 France: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 22 Germany: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Germany: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 25 Italy: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 27 Italy: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 28 Spain: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Spain: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 34 Russia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Russia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 43 China: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 45 China: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 46 India: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 48 India: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 52 Japan: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Japan: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 58 South Korea: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 60 South Korea: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 61 Australia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 63 Australia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 73 UAE: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 75 UAE: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 76 Israel: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 78 Israel: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 79 South Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 81 South Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 85 Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 87 Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 88 Mexico: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 90 Mexico: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 91 Brazil: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 93 Brazil: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 94 Argentina: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 96 Argentina: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Oncology Based Molecular Diagnostics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Oncology Based Molecular Diagnostics Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Oncology Based Molecular Diagnostics Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Oncology Based Molecular Diagnostics Market, by Technology, 2024 & 2034 (USD Billion)